Sign In
Buy NUVA
$39.75
+0 (+0%)
At Close: Nov 30, 2023
This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. Global Stem Cell Therap
Northland Securities Issues a Hold Rating on NuVasive (NUVA) - Markets
11:41am, Thursday, 25'th Jun 2020
Northland Securities analyst Jason Wittes assigned a Hold rating to NuVasive (NUVA – Research Report) today and set a price
The Intraoperative Neuromonitoring Market in US will grow by USD 955.33 mn during 2020-2024
What Made Needham Upgrade NuVasive's Stock? - Markets
10:09am, Tuesday, 23'rd Jun 2020
In a report released today, Michael Matson from Needham upgraded NuVasive (NUVA – Research Report) to Buy, with a price
NuVasive Launches Reline 3D for Pediatric Patients Globally
03:08pm, Monday, 22'nd Jun 2020
Other than Reline 3D, NuVasive's (NUVA) Reline System portfolio has products like Reline Open, Reline MAS, Reline Trauma and Reline Small Stature.
Here's Why You Should Hold on to NuVasive (NUVA) Stock Now
01:24pm, Monday, 22'nd Jun 2020
Investors are optimistic about NuVasive (NUVA) on continued momentum across several recently-launched products as well as solid international business.
Geode Capital Management LLC Grows Stock Holdings in NuVasive, Inc. (NASDAQ:NUVA)
09:24am, Monday, 22'nd Jun 2020
Geode Capital Management LLC raised its position in shares of NuVasive, Inc. (NASDAQ:NUVA) by 6.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund own
Mackenzie Financial Corp Makes New Investment in NuVasive, Inc. (NASDAQ:NUVA)
07:54am, Monday, 22'nd Jun 2020
Mackenzie Financial Corp purchased a new position in shares of NuVasive, Inc. (NASDAQ:NUVA) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional
Ortho Pediatric Devices Market 2019-2023 | Increasing M&A Activities to Boost Growth | Technavio
12:00am, Monday, 22'nd Jun 2020
The Global Ortho Pediatric Devices Market will grow by USD 902.23 mn during 2019-2023
Market Segmentation & Coverage: This research report categorizes the Cell Therapy to forecast the revenues and analyze the trends in each of the following sub-markets: On the basis of Cell Type, the C
NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity
12:33pm, Thursday, 18'th Jun 2020
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the expans
Dr. Frank Phillips is First in the World to Use Augmented Reality Surgical Guidance in Minimally Invasive Spine Surgery
12:00am, Wednesday, 17'th Jun 2020
Augmedics and Midwest Orthopaedics at Rush announce world's first augmented reality minimally invasive spine surgery using xvision Spine System.
Nuvasive Shows Improved Relative Price Performance; Still Shy Of Benchmark
09:40pm, Monday, 15'th Jun 2020
A Relative Strength Rating upgrade for Nuvasive shows improving technical performance. Will it continue?
NuVasive, Inc. (NUVA): Hedge Funds Taking Some Chips Off The Table
07:05pm, Monday, 15'th Jun 2020
In this article you are going to find out whether hedge funds think NuVasive, Inc. (NASDAQ:NUVA) is a good investment right now. We like to check what the smart money thinks first before doing extensi
NuVasive (NASDAQ:NUVA) Rating Reiterated by Credit Suisse Group
03:20am, Sunday, 14'th Jun 2020
NuVasive (NASDAQ:NUVA)‘s stock had its “buy” rating reiterated by Credit Suisse Group in a note issued to investors on Friday, TipRanks reports. They presently have a $74.00 target price on the
